Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PER2 | O15055 | 1/20 | 0.35 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8283279 | 0.86 | — | — | |
| Hydrochloric Acid SCHEMBL31019532 | 0.84 | RAB9A (0.31) | RAB9ASMN1; SMN2 | |
| SCHEMBL761946 | 0.74 | GRIN1 (0.42) | PER2CRY2RAB9ASMN1; SMN2POLB | |
| SCHEMBL13632872 | 0.74 | PER2 (0.43) | PER2CRY2MEN1KMT2APOLB | |
| SCHEMBL14378051 | 0.73 | POLB (0.41) | PER2CRY2MEN1KMT2ARAB9A | |
| SCHEMBL12600979 | 0.72 | PER2 (0.42) | PER2CRY2MEN1KMT2APOLB | |
| SCHEMBL22833746 | 0.71 | TSHR (0.51) | PER2CRY2MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL8282896 | 0.70 | PIK3CD (0.52) | PER2CRY2MEN1KMT2APOLB | |
| SCHEMBL21389411 | 0.70 | PER2 (0.43) | PER2CRY2MEN1KMT2APOLB | |
| SCHEMBL9576643 | 0.70 | PER2 (0.31) | PER2CRY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992003415-A1 | PROTEIN KINASE C MODULATORS | NOVA PHARMACEUTICAL CORPORATION (US) | 1992-03-05 | — | — | WO | disclosed |